ARCHIVES

FDA Approves Taxotere For Node+ Breast Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

FCRF Recompetition Intriguing, Involved Various Possibility

May 9, 1986

In Brief: Knowledge Surgeons, Radiotherapists, Pathologists Untapped, Zubrod Suggests

February 20, 1976

NCI Plans To Issue Frederick Operations Contract As Sole-Source To SAIC-Frederick Inc. For Up To 10 Years.

November 10, 2006

Avon Gives $3 Million To Expand CDC’s Screening Program

February 18, 1994

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Pilot Study Tests Novel “Metronomic” Delivery

December 30, 2005